For example, in MCF-7 DOX-resistant BC cells, lncRNA cancer susceptibility candidate 9 (CASC9) binds to enhancer of zeste homolog 2 (EZH2) to promote its expression, resulting in P-gp upregulation [130]. Here, EZH2 is linked to breast cancer.